252 related articles for article (PubMed ID: 37125432)
1. Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy.
Hojjatipour T; Maali A; Azad M
Epigenomics; 2023 Feb; 15(4):249-266. PubMed ID: 37125432
[TBL] [Abstract][Full Text] [Related]
2. Localization Matters: Epigenetic Regulation of Natural Killer Cells in Different Tissue Microenvironments.
Wiedemann GM
Front Immunol; 2022; 13():913054. PubMed ID: 35707540
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity.
Xia M; Wang B; Wang Z; Zhang X; Wang X
Front Immunol; 2021; 12():672328. PubMed ID: 34017344
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells.
Bugide S; Janostiak R; Wajapeyee N
Trends Cancer; 2018 Aug; 4(8):553-566. PubMed ID: 30064663
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity.
Naeimi Kararoudi M; Tullius BP; Chakravarti N; Pomeroy EJ; Moriarity BS; Beland K; Colamartino ABL; Haddad E; Chu Y; Cairo MS; Lee DA
Semin Hematol; 2020 Oct; 57(4):201-212. PubMed ID: 33256913
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.
Shaver KA; Croom-Perez TJ; Copik AJ
Front Immunol; 2021; 12():679117. PubMed ID: 33995422
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cells--An Epigenetic Perspective of Development and Regulation.
Schenk A; Bloch W; Zimmer P
Int J Mol Sci; 2016 Mar; 17(3):326. PubMed ID: 26938533
[TBL] [Abstract][Full Text] [Related]
8. Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.
Pierce S; Geanes ES; Bradley T
Front Cell Infect Microbiol; 2020; 10():231. PubMed ID: 32509600
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells at the forefront of cancer immunotherapy with immune potency, genetic engineering, and nanotechnology.
Pan W; Tao T; Qiu Y; Zhu X; Zhou X
Crit Rev Oncol Hematol; 2024 Jan; 193():104231. PubMed ID: 38070841
[TBL] [Abstract][Full Text] [Related]
10. Natural killer group 2D receptor and its ligands in cancer immune escape.
Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
[TBL] [Abstract][Full Text] [Related]
11. Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer.
Iyoda T; Yamasaki S; Ueda S; Shimizu K; Fujii SI
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830717
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Regulation of Cancer Immune Cells.
Avella Patino DM; Radhakrishnan V; Suvilesh KN; Manjunath Y; Li G; Kimchi ET; Staveley-O'Carroll KF; Warren WC; Kaifi JT; Mitchem JB
Semin Cancer Biol; 2022 Aug; 83():377-383. PubMed ID: 34182142
[TBL] [Abstract][Full Text] [Related]
13. Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.
Cifaldi L; Locatelli F; Marasco E; Moretta L; Pistoia V
Trends Mol Med; 2017 Dec; 23(12):1156-1175. PubMed ID: 29133133
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy.
Zhang M; Lam KP; Xu S
Front Immunol; 2023; 14():1207276. PubMed ID: 37638058
[TBL] [Abstract][Full Text] [Related]
15. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
16. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells as a promising therapeutic target for cancer immunotherapy.
Kim N; Lee HH; Lee HJ; Choi WS; Lee J; Kim HS
Arch Pharm Res; 2019 Jul; 42(7):591-606. PubMed ID: 30895524
[TBL] [Abstract][Full Text] [Related]
18. Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity.
Rafei H; Daher M; Rezvani K
Br J Haematol; 2021 Apr; 193(2):216-230. PubMed ID: 33216984
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.
Wu Y; Li J; Jabbarzadeh Kaboli P; Shen J; Wu X; Zhao Y; Ji H; Du F; Zhou Y; Wang Y; Zhang H; Yin J; Wen Q; Cho CH; Li M; Xiao Z
Pharmacol Res; 2020 May; 155():104691. PubMed ID: 32070721
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications.
Yin J; Gu T; Chaudhry N; Davidson NE; Huang Y
Front Immunol; 2023; 14():1325615. PubMed ID: 38268926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
